BRIEF published on 08/06/2024 at 09:06, 2 years 1 month ago Original-Research: LAIQON AG Receives "BUY" Recommendation from NuWays AG Investment Capital Increase NuWays AG LAIQON AG Undervalued
BRIEF published on 08/06/2024 at 09:06, 2 years 1 month ago Recherche originale : LAIQON AG reçoit la recommandation « ACHETER » de NuWays AG Investissement Augmentation De Capital LAIQON AG NuWays SA Sous-évalué
BRIEF published on 08/06/2024 at 09:05, 2 years 1 month ago Biotest Sees 35% Sales Spike in First Half of 2024 Financial Results Revenue Growth FDA Approval Biotest Yimmugo®
BRIEF published on 08/06/2024 at 09:05, 2 years 1 month ago Biotest voit ses ventes augmenter de 35 % au premier semestre 2024 Résultats Financiers Hausse Des Revenus Approbation De La FDA Biotest Yimmugo®
BRIEF published on 08/06/2024 at 09:05, 2 years 1 month ago Northern Data Group announces Q2 Results, reaffirms 2024 guidance Revenue Growth Q2 Results Capital Raise Nvidia GPUs HPC Infrastructure
BRIEF published on 08/06/2024 at 09:05, 2 years 1 month ago Northern Data Group annonce ses résultats du deuxième trimestre et réaffirme ses prévisions pour 2024 Augmentation De Capital Hausse Des Revenus Résultats Du Deuxième Trimestre GPU Nvidia Infrastructure HPC
BRIEF published on 08/06/2024 at 08:36, 2 years 1 month ago Cherry SE Releases 2024 Half-Year Report Adjusted EBITDA Revenue Growth Half-year Report Cherry SE 2024 Forecast
BRIEF published on 08/06/2024 at 08:36, 2 years 1 month ago Cherry SE publie son rapport semestriel 2024 Prévisions 2024 EBITDA Ajusté Hausse Des Revenus Cerise SE Rapport Semestriel
BRIEF published on 08/06/2024 at 08:35, 2 years 1 month ago Abivax franchit une étape clé avec le recrutement de 600 patients pour l'essai de phase 3 ABTECT Abivax Obefazimod Rectocolite Hémorragique Essai Clinique Recrutement Patients
BRIEF published on 08/06/2024 at 08:35, 2 years 1 month ago Abivax Reaches Key Milestone with Recruitment of 600 Patients for Phase 3 ABTECT Trial Patient Recruitment Abivax Obefazimod Ulcerative Colitis Clinical Test
Published on 09/11/2026 at 04:00, 5 hours 14 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 10 hours 49 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 17 hours 54 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 14 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:05, 9 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 14 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 09:00, 14 minutes ago Mountain Alliance AG invests in Evolved Aerospace and expands its involvement in the European defence technology market
Published on 09/11/2026 at 07:00, 2 hours 14 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 14 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 14 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 13 hours 44 minutes ago Availability of the 2026 Interim Financial Report
